Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0038389992
Mon, 20.05.2024       Edison Investment Research Limited

  London, UK, 20 May 2024   Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its investment company peers, focused on high-quality biotech assets that target substantial [ … ]
Thu, 21.03.2024       BB BIOTECH AG

Media release of March 21, 2024 Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today. Shareholders voted in favor of the proposal to pay out a divi [ … ]
Fri, 16.02.2024       BB BIOTECH AG

Ad hoc announcement pursuant to Art. 53 LR February 16, 2024 Annual report of BB Biotech AG as at December 31, 2023  BB Biotech AG publishes its 2023 annual report BB Biotech AG published its annual report for fiscal year 2023 today. Besides the audited consolidated financial statements, the annual report contains detailed information on the bi [ … ]
Wed, 14.02.2024       BB BIOTECH AG

Release as at February 14, 2024Investor interest returns – dividend yield remains high for 2024 After a difficult 2023 stock market year, above all due to higher interest rates, the capital markets are now once again looking at biotech companies with interest. The prospect of falling interest rates has led to a rethink. While the majority of inves [ … ]
Fri, 19.01.2024       BB BIOTECH AG

Ad hoc announcement pursuant to Art. 53 LR January 19, 2024 BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN CH0038389992) is releasing the following information: Results for the financial year 2023 Based on its preliminary unaudited  [ … ]
Fri, 19.01.2024       BB BIOTECH AG

Media release as at January 19, 2024 Portfolio of BB Biotech AG as at December 31, 2023 End of year biotech equity market rally – M&A and end of rate hike cycle In 2023, global equity performed better than anticipated by many. The US central bank moderated and then paused interest rate hikes. These developments resulted in a year-end bond ma [ … ]
Fri, 20.10.2023       BB BIOTECH AG

Ad hoc announcement pursuant to Art. 53 LR October 20, 2023 BB Biotech AG publishes its interim report BB Biotech AG (ISIN CH0038389992) today published its interim report as at September 30, 2023, which covers the results of its business activities for the first nine months of 2023. Based on the consolidated accounts of BB Biotech AG, net loss [ … ]
Fri, 20.10.2023       BB BIOTECH AG

Media release as at October 20, 2023 Interim report of BB Biotech AG as at September 30, 2023 Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies Expectations that the US central bank would soon reverse its monetary policy stance proved to be premature. The rise in bond yields weighed heavily on biot [ … ]
Fri, 21.07.2023       BB BIOTECH AG

Ad hoc announcement pursuant to Art. 53 LR July 21, 2023 BB Biotech AG publishes its interim report BB Biotech AG (ISIN CH0038389992) today published its interim report as at June 30, 2023, which covers the results of its business activities for the first six months of 2023. Based on the consolidated accounts of BB Biotech AG, net loss for the  [ … ]
Fri, 21.07.2023       BB BIOTECH AG

Media release as at July 21, 2023 Interim report of BB Biotech AG as at June 30, 2023 Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry The first half of 2023 has been disappointing for biotech investors. A massive rotation has put biotech stocks under pressure. Whereas [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 16.06.2024, Calendar Week 24, 168th day of the year, 198 days remaining until EoY.